August 26, 2025
Proactive MSK Care whitepaper: Reverse inactivity with Move's 3:1 ROI
Musculoskeletal (MSK) pain is a hidden cost driver impacting so many employers and health insurers.
Often starting as mild discomfort, MSK issues like back, neck pain, knee, and shoulder issues can escalate into chronic pain, productivity loss, and costly surgeries. But what if you could stop this progression early?
This Sword white paper outlines why many MSK claims are avoidable and how Sword Move delivers proactive care to slash MSK healthcare spend.
3:1
Return on investment ratio independently validated by the Validation Institute
$1,663
Average MSK care savings per member per year with Sword Move
Inside the whitepaper
Learn how Move's proactive care stops pain and MSK costs before they escalate.
This white paper gives health plan managers and benefits leaders an in-depth analysis of how Move tackles low-grade pain, reverses physical inactivity risks, and delivers verified savings at scale. You'll learn how move delivers results like these at scale:
- Strong clinical improvement: 91% of members report improvements1
- Increased physical activity: 69% of inactive and Insufficiently active members reached active or healthy active levels within 10 weeks2
- Significant pain reduction: 47% of members with moderate or high pain moved to pain-free3
- Mental health improvements: Over half of the members with moderate to severe symptoms recovered to non-clinical levels of anxiety (60%) and depression (59%)4
Complete the form now to access the Proactive MSK Care whitepaper by email and learn how Move can deliver huge cost savings with smart preventative care.
Contributors to White Paper

Sword Editorial Team
Experts in pain, movement, and digital health
Footnotes
Percent of members who scored 5 or above on the PGIC scale from all of those who have answered a reassessment, +9 DWA.
Over 500 MET-minutes per week, self-reported sitting time at the latest reassessment on or after 5 weeks into the program
Percent of members who started therapy with a pain level of 4 or above, and scored less than 4 on their last reassessment OR improved 30% or more in pain level, +9DWA
Percent of members who started therapy scoring 10 or above on PHQ-9 or GAD-7 scale, and scored less then 10 on their last reassessment, +9DWA